BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:18 PM
May 06, 2009
 |  BC Extra  |  Company News

Fampridine-SR gets Priority Review

Acorda Therapeutics Inc. (NASDAQ:ACOR) gained $3.31 (17%) to $22.81 on Wednesday after FDA accepted for filing and...

Read the full 70 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >